Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis

Comparative Effectiveness and Safety of Anti–Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn’s Disease

(2016) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Comparative Effectiveness of Infliximab and Adalimumab in Crohnʼs Disease and Ulcerative Colitis

(2016) Ashwin N. Ananthakrishnan et al.   INFLAMMATORY BOWEL DISEASES

Anti-TNF Therapy Within 2 Years of Crohnʼs Disease Diagnosis Improves Patient Outcomes

(2016) Christopher Ma et al.   INFLAMMATORY BOWEL DISEASES

Inflammatory Bowel Disease: A Canadian Burden of Illness Review

(2016) Angela Rocchi et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

(2015) L Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials

(2015) Anthony Lopez et al.   DIGESTIVE AND LIVER DISEASE

Postoperative Mortality Among Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis of Population-Based Studies

(2015) Sunny Singh et al.   GASTROENTEROLOGY

Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis

(2015) Glen S. Hazlewood et al.   GASTROENTEROLOGY

Development of the Lémann Index to Assess Digestive Tract Damage in Patients With Crohn's Disease

(2015) Benjamin Pariente et al.   GASTROENTEROLOGY

Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs

(2015) Kristian Thorlund et al.   Expert Review of Gastroenterology & Hepatology

Biologics in inflammatory bowel disease: what are the data?

(2015) Justin Côté-Daigneault et al.   United European Gastroenterology Journal

Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease

(2014) R. W. Stidham et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis

(2014) R. W. Stidham et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Biological Agents for Moderately to Severely Active Ulcerative Colitis

(2014) Silvio Danese et al.   ANNALS OF INTERNAL MEDICINE

Comparative Efficacy of Biologic Therapy in Biologic-Naïve Patients With Crohn Disease: A Systematic Review and Network Meta-analysis

(2014) Siddharth Singh et al.   MAYO CLINIC PROCEEDINGS

Dual Therapy With Infliximab and Immunomodulator Reduces One-Year Rates of Hospitalization and Surgery Among Veterans With Inflammatory Bowel Disease

(2013) Neena S. Abraham et al.   Clinical Gastroenterology and Hepatology

Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti–Tumor Necrosis Factor-α Agents

(2013) Christine Kestens et al.   Clinical Gastroenterology and Hepatology

Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease

(2013) Mark T. Osterman et al.   Clinical Gastroenterology and Hepatology

Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease

(2013) Julián Panés et al.   GASTROENTEROLOGY

American Gastroenterological Association Institute Technical Review on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease

(2013) Themistocles Dassopoulos et al.   GASTROENTEROLOGY

Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies

(2013) Alexandra D. Frolkis et al.   GASTROENTEROLOGY

Adalimumab Therapy Is Associated With Reduced Risk of Hospitalization in Patients With Ulcerative Colitis

(2013) Brian G. Feagan et al.   GASTROENTEROLOGY

Infliximab Reduces Hospitalizations and Surgery Interventions in Patients With Inflammatory Bowel Disease

(2013) João Costa et al.   INFLAMMATORY BOWEL DISEASES

The burden of inflammatory bowel disease in Europe

(2013) Johan Burisch et al.   Journal of Crohns & Colitis

Decreasing Colectomy Rates for Ulcerative Colitis: A Population-Based Time Trend Study

(2012) Gilaad G Kaplan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Epidemiology of Colectomy in Ulcerative Colitis: Results From a Population-Based Cohort

(2012) Laura E Targownik et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Hospitalisations and surgery in Crohn's disease

(2012) Charles N Bernstein et al.   GUT

Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)

(2012) Daniel A. Sussman et al.   INFLAMMATORY BOWEL DISEASES

Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews

(2012) Rebecca M Turner et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Ulcerative colitis

(2012) Ingrid Ordás et al.   LANCET

Crohn's disease

(2012) Daniel C Baumgart et al.   LANCET

Evidence Synthesis for Decision Making 2

(2012) Sofia Dias et al.   MEDICAL DECISION MAKING

Review article: remission rates achievable by current therapies for inflammatory bowel disease

(2011) L. Peyrin-Biroulet et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

(2011) Natalie A. Molodecky et al.   GASTROENTEROLOGY

Direct Medical Cost of Managing IBD Patients: A Canadian Population-based Study

(2011) Charles N. Bernstein et al.   INFLAMMATORY BOWEL DISEASES

Systematic review: the costs of ulcerative colitis in Western countries

(2010) R. D. COHEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?

(2010) Geert R D'Haens et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Natural History of Adult Crohn's Disease in Population-Based Cohorts

(2009) Laurent Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease

(2009) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin

(2008) Brian G. Feagan et al.   Clinical Gastroenterology and Hepatology

Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study

(2008) Brian G. Feagan et al.   GASTROENTEROLOGY

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

(2008) F Schnitzler et al.   GUT

History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis

(2008) Ashwin N. Ananthakrishnan et al.   INFLAMMATORY BOWEL DISEASES

How expensive is inflammatory bowel disease? A critical analysis

(2008) Selwyn Odes   WORLD JOURNAL OF GASTROENTEROLOGY